[PHARMA] YoY Cumulative Quarter Result on 30-Jun-2010 [#2]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
11-Aug-2010
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2010
Quarter
30-Jun-2010 [#2]
Profit Trend
QoQ- 158.45%
YoY- -25.34%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Cumulative Result
30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 CAGR
Revenue 937,972 903,482 781,763 667,895 646,928 663,115 556,466 9.08%
PBT 46,529 70,573 41,172 32,758 44,521 48,462 22,411 12.93%
Tax -15,205 -25,435 -11,528 -8,931 -11,305 -16,023 -8,701 9.74%
NP 31,324 45,138 29,644 23,827 33,216 32,439 13,710 14.74%
-
NP to SH 30,636 44,398 29,404 24,054 32,219 31,652 12,709 15.77%
-
Tax Rate 32.68% 36.04% 28.00% 27.26% 25.39% 33.06% 38.82% -
Total Cost 906,648 858,344 752,119 644,068 613,712 630,676 542,756 8.91%
-
Net Worth 481,681 481,282 451,381 417,306 400,063 362,623 314,515 7.35%
Dividend
30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 CAGR
Div 17,661 17,650 - 50,290 28,881 19,254 16,046 1.60%
Div Payout % 57.65% 39.76% - 209.07% 89.64% 60.83% 126.26% -
Equity
30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 CAGR
Net Worth 481,681 481,282 451,381 417,306 400,063 362,623 314,515 7.35%
NOSH 258,968 117,672 106,962 107,001 106,968 106,968 106,978 15.86%
Ratio Analysis
30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 CAGR
NP Margin 3.34% 5.00% 3.79% 3.57% 5.13% 4.89% 2.46% -
ROE 6.36% 9.22% 6.51% 5.76% 8.05% 8.73% 4.04% -
Per Share
30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 CAGR
RPS 362.20 767.79 730.88 624.19 604.78 619.92 520.17 -5.84%
EPS 11.83 37.73 27.49 22.48 30.12 29.59 11.88 -0.07%
DPS 6.82 15.00 0.00 47.00 27.00 18.00 15.00 -12.29%
NAPS 1.86 4.09 4.22 3.90 3.74 3.39 2.94 -7.34%
Adjusted Per Share Value based on latest NOSH - 106,939
30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 CAGR
RPS 65.08 62.69 54.24 46.34 44.89 46.01 38.61 9.08%
EPS 2.13 3.08 2.04 1.67 2.24 2.20 0.88 15.85%
DPS 1.23 1.22 0.00 3.49 2.00 1.34 1.11 1.72%
NAPS 0.3342 0.3339 0.3132 0.2895 0.2776 0.2516 0.2182 7.35%
Price Multiplier on Financial Quarter End Date
30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 CAGR
Date 28/06/13 29/06/12 30/06/11 30/06/10 30/06/09 30/06/08 29/06/07 -
Price 4.49 10.18 5.90 4.98 3.80 3.27 3.53 -
P/RPS 1.24 1.33 0.81 0.80 0.63 0.53 0.68 10.52%
P/EPS 37.95 26.98 21.46 22.15 12.62 11.05 29.71 4.16%
EY 2.63 3.71 4.66 4.51 7.93 9.05 3.37 -4.04%
DY 1.52 1.47 0.00 9.44 7.11 5.50 4.25 -15.73%
P/NAPS 2.41 2.49 1.40 1.28 1.02 0.96 1.20 12.31%
Price Multiplier on Announcement Date
30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 CAGR
Date 16/08/13 08/08/12 10/08/11 11/08/10 21/08/09 14/08/08 17/08/07 -
Price 4.66 8.83 5.90 4.95 4.00 3.44 3.44 -
P/RPS 1.29 1.15 0.81 0.79 0.66 0.55 0.66 11.80%
P/EPS 39.39 23.40 21.46 22.02 13.28 11.63 28.96 5.25%
EY 2.54 4.27 4.66 4.54 7.53 8.60 3.45 -4.97%
DY 1.46 1.70 0.00 9.49 6.75 5.23 4.36 -16.65%
P/NAPS 2.51 2.16 1.40 1.27 1.07 1.01 1.17 13.55%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment